[ET Net News Agency, 28 April 2025] HANSOH PHARMA (03692) fell 3.6% to HK$23.05.
It hits an intra-day low of HK$22.85, dipping below the 20-D SMA of HK$22.928, and an intra-day high of HK$24.3. The total shares traded was 1.11 million, with a value of HK$26.1m. The active buy/sell ratio is 24:76, with net selling turnover of HK$11.74m. ABN AMRO CLEARING HK accounts for greatest net responsive buying turnover of HK$2.56m, with volume weighted average price of HK$23.507. UBS accounts for greatest net responsive selling turnover of HK$526,000, with volume weighted average price of HK$23.854. The stock has fallen a combined 4.9% over the past 2 consecutive trading days.
The Hang Seng Index now fell 115 points, or 0.5% to 21,865.
Basic Information| Nominal | 23.050 | % Chg | -3.56% |
| High | 24.300 | Low | 22.850 |
| Shares Tr | 1.11m | Turnover | 26.1m |
| 10-D SMA | 22.995 | %H.V | 69.113 |
| 20-D SMA | 22.928 | VWAP | 23.468 |
| 50-D SMA | 20.626 | RSI14 | 55.616 |
Status: Dipping below the 20-D SMA, active buy/sell ratio is 24:76, with net selling turnover of HK$11.74m, falling a combined 4.9% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 23.05 | -3.56 |
| SIHUAN PHARM (00460) | 0.67 | +1.52 |
| GRAND PHARMA (00512) | 5.77 | -1.54 |
| SINO BIOPHARM (01177) | 3.79 | -4.05 |
| LIVZON PHARMA (01513) | 26.40 | -1.12 |
| LUYE PHARMA (02186) | 1.98 | -1.00 |
| FOSUN PHARMA (02196) | 14.80 | -0.27 |
| SH PHARMA (02607) | 10.74 | -0.37 |
| CHINARES PHARMA (03320) | 4.91 | -0.20 |
| GOLDEN THROAT (06896) | 4.29 | +2.39 |
(ed)
